Literature DB >> 3135921

Polyamine metabolism in reversible cerebral ischemia: effect of alpha-difluoromethylornithine.

W Paschen1, G Röhn, C O Meese, B Djuricic, R Schmidt-Kastner.   

Abstract

Severe forebrain ischemia was produced in rats by occluding both carotid and vertebral arteries. Following 30 min ischemia brains were recirculated for 8 or 24 h. Twelve animals subjected to 8 or 24 h recirculation (n = 6, each group) were given alpha-difluoromethylornithine (DFMO; injected intraperitoneally) immediately before recirculation. At the end of the experiments brains were frozen and samples were taken from the cerebellum, cortex, caudatoputamen and hippocampus. Samples from the left hemisphere were used for measuring ornithine decarboxylase (ODC) activity, and those from the right hemisphere for determining putrescine profiles. During recirculation ODC activity increased markedly in all brain structures, the most pronounced change being in the caudatoputamen after 8 h recirculation. Putrescine increased drastically after 8 h and even more after 24 h recirculation. DFMO-treatment significantly reduced ODC activity after 8 h recirculation and following 24 h recirculation. Putrescine, however, was significantly reduced following 24 h but not after 8 h recirculation. The discrepancy between reduction in ODC activity and putrescine levels in DFMO-treated animals was most prominent in the hippocampus after 8 h recirculation: here DFMO reduced ODC activity to control values without affecting putrescine levels. The results suggest that the observed overshoot in putrescine formation following ischemia is only partly caused by activation of ODC.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135921     DOI: 10.1016/0006-8993(88)90138-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Natural polyamines stimulate G-proteins.

Authors:  J L Bueb; A Da Silva; M Mousli; Y Landry
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Ornithine decarboxylase activity in cerebral post-ischemic reperfusion damage: effect of methionine sulfoximine.

Authors:  C Di Giacomo; V Sorrenti; R Acquaviva; A Campisi; G Vanella; J R Perez-Polo; A Vanella
Journal:  Neurochem Res       Date:  1997-09       Impact factor: 3.996

3.  Ornithine decarboxylase in reversible cerebral ischemia: an immunohistochemical study.

Authors:  M Müller; M Cleef; G Röhn; P Bonnekoh; A E Pajunen; H G Bernstein; W Paschen
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 4.  Oxidation of polyamines and brain injury.

Authors:  N Seiler
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

Review 5.  Receptor-receptor interactions as an integrative mechanism in nerve cells.

Authors:  M Zoli; L F Agnati; P B Hedlund; X M Li; S Ferré; K Fuxe
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

6.  Changes in striatal dopamine neurohistochemistry and biochemistry after incomplete transient cerebral ischemia in the rat.

Authors:  G Németh; A Cintra; J M Herb; A Ding; M Goldstein; L F Agnati; S Hoyer; K Fuxe
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

7.  Polyamine metabolism in brain tumours: diagnostic relevance of quantitative biochemistry.

Authors:  R I Ernestus; G Röhn; R Schröder; T Els; W Paschen; N Klug
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-07       Impact factor: 10.154

8.  Acidosis mediates recurrent hypoglycemia-induced increase in ischemic brain injury in treated diabetic rats.

Authors:  Ashish K Rehni; Vibha Shukla; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Neuropharmacology       Date:  2018-03-15       Impact factor: 5.250

9.  Polyamine metabolism in reversible cerebral ischemia of Mongolian gerbils.

Authors:  W Paschen; G Röhn; J Hallmayer; G Mies
Journal:  Metab Brain Dis       Date:  1988-12       Impact factor: 3.584

10.  Polyamine metabolism in gliomas.

Authors:  R I Ernestus; G Röhn; R Schröder; T Els; J Y Lee; N Klug; W Paschen
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.